Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, it added.from Top Business News- News18.com https://ift.tt/2W8BC3i
Biocon Gets DCGI Nod for Emergency Use of Itolizumab for Treatment of Covid-19 Patients
Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, it added.from Top Business News- News18.com https://ift.tt/2W8BC3i
Related Posts
PNB Board to Meet on September 5 to Consider Merger with OBC, United Bank
L&T IDPL Bags EPC Contract for Navi Mumbai Airport
Union Bank of India Cuts MCLR across Various Tenors from September 1
Apple Mulls 2-3 Physical, an Online Retail Store in India Soon After Govt Relaxed FDI Norms
Govt Accepts State Bank of India MD Anshula Kant's Resignation
0 comments: